These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4746588)

  • 21. Inhibitory effects of atropine on growth hormone release in normal subjects and acromegaly.
    Zhang J; Lu JM; Huang ZJ
    Chin Med J (Engl); 1989 Jan; 102(1):45-7. PubMed ID: 2504552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early effect of acromegaly on the heart: analysis of 28 cases].
    Hu GX
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):269-71, 317-8. PubMed ID: 4053791
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acromegaly and thyroid function].
    Muñoz Torres M; Escobar Jiménez F; Torres Vela E; Díaz Pérez de Madrid J; Vílchez Joya R; de la Higuera Rojas J
    Med Clin (Barc); 1985 Feb; 84(7):268-71. PubMed ID: 3982145
    [No Abstract]   [Full Text] [Related]  

  • 25. The secretion rate of human growth hormone. II. Acromegaly, effect of chlorpromazine treatment.
    Alford FP; Baker HW; Burger HG; Cameron DP; Keogh EJ
    J Clin Endocrinol Metab; 1974 Feb; 38(2):309-12. PubMed ID: 4812624
    [No Abstract]   [Full Text] [Related]  

  • 26. The response of serum growth hormone to central and peripheral dopaminergic stimuli in normal subjects and in acromegalic patients.
    Oma H; Kato K; Takahashi H; Ibayashi H
    Fukuoka Igaku Zasshi; 1982 Mar; 73(3):179-88. PubMed ID: 7106688
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies of hypothalamic control of somatotropin incretion in acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Cremascoli G; Tosi M
    Folia Endocrinol; 1973 Dec; 26(6):503-9. PubMed ID: 4801261
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acromegaly].
    Lindholm J; Korsgaard O; Rasmussen P; Kappelgaard AM
    Ugeskr Laeger; 1973 Jan; 135(4):183-7. PubMed ID: 4346376
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioimmunoassay evaluation of somatotropin in acromegalics. Effect of tolbutamide].
    Scornavachi JC; Comini E; Altschuler N; Andrada JA
    Medicina (B Aires); 1971; 31(4):317-22. PubMed ID: 5129005
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of alcohol on growth hormone secretion in acromegaly.
    Tamburrano G; Tamburrano S; Gambardella S; Andreani D
    J Clin Endocrinol Metab; 1976 Jan; 42(1):193-6. PubMed ID: 1249189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary studies of plasma growth hormone releasing activity during medical therapy of acromegaly.
    Hagen TC; Lawrence AM; Kirsteins L
    Horm Metab Res; 1978 Jul; 10(4):310-3. PubMed ID: 98420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
    Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of apomorphine on the secretion of prolactin in florid acromegaly].
    Heesen D; Baumgarten G; Fricke U; Hadam W; Mies R; Winkelmann W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1902-4. PubMed ID: 1030132
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acromegaly].
    Warnet A
    Soins; 1988 Jul; (514):26-30. PubMed ID: 2903558
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypersecretion of arginine vasopressin in acromegaly.
    Doyle MJ; Lopez-Amor E; Dingman JF
    J Clin Endocrinol Metab; 1971 Sep; 33(3):418-23. PubMed ID: 4936882
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
    Sachdev Y
    J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
    [No Abstract]   [Full Text] [Related]  

  • 38. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
    Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
    Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acromegaly].
    Katakami H
    Nihon Rinsho; 2006 May; Suppl 1():129-38. PubMed ID: 16776111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.